
Can FAPI PET Enhance Pre-Op Evaluation of Peritoneal Carcinomatosis?
Preoperative use of (68Ga)Ga-FAPI-46 PET/CT demonstrated an 81 percent intraclass correlation coefficient (ICC) with the intraoperative peritoneal cancer index (PCI) in comparison to 76 percent for MRI and 54 percent for (18F)FDG PET/CT (FDG PET), according to new research presented at the SNMMI conference.
Emerging research suggests that (68Ga)Ga-FAPI-46 PET/CT may provide improved pre-operative assessment of patients with peritoneal carcinomatosis.
For the study, recently presented at the
The study authors found that (68Ga)Ga-FAPI-46 PET/CT demonstrated an 81 percent interclass correlation coefficient (ICC) with the intraoperative peritoneal cancer index (PCI) in comparison to 76 percent for MRI and 54 percent for (18F)FDG PET/CT.
Additionally, in a sub-analysis of patients who had chemotherapy in the previous three months, the researchers noted a 75 percent ICC for (68Ga)Ga-FAPI-46 PET/CT in contrast to 65 percent for MRI and 46 percent for (18F)FDG PET/CT.
“(68Ga)Ga-FAPI-46 PET/CT demonstrated the strongest agreement with surgico-pathological PCI and maintained good agreement after recent chemotherapy,” noted lead study author Ayca Arcay Ozturk, MD, a doctoral research fellow at Institut Jules Bordet in Brussels, Belgium, and colleagues.
(Editor’s note: For additional coverage from the SNMMI conference, click
The researchers noted that (68Ga)Ga-FAPI-46 PET/CT demonstrated the highest segment-level sensitivity (77.6 percent) in comparison to MRI (67 percent) and (18F)FDG PET/CT (47.5 percent), but also had the lowest segment-level specificity (71.2 percent vs. 84.4 percent for MRI and 91.8 percent for (18F)FDG PET/CT).
The study authors added that (68Ga)Ga-FAPI-46 PET/CT offered a significantly higher SUVmax (13 vs. 6.15) and total lesion uptake (193.05 vs. 29.40) than (18F)FDG PET/CT.
“((68Ga)Ga-FAPI-46 PET/CT showed higher detectability than MRI and (18F)FDG PET/CT, albeit at the expense of lower specificity. These findings support (68Ga)Ga-FAPI-46 PET/CT as a promising modality for preoperative PC mapping,” maintained Ozturk and colleagues.
(Editor’s note: For related content, see “
Reference
- Ozturk AA, Deleu AL, Poenaru R, et al. Preoperative assessment of peritoneal carcinomatosis with (68Ga)Ga-FAPI-46 PET/CT. Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI), May 30-June 2, 2026, Los Angeles. Available at:
https://jnm.snmjournals.org/content/67/supplement_1/261990 .















